Virologists studying COVID-19 have concluded that respiratory coronavirus infection should not be rushed to treat new methods. This can lead to poor health. The effects of new therapeutic methods on COVID-19 are being investigated by Benjamin Singer. He is a doctor of medical sciences, assistant professor of medicine and biochemistry and molecular genetics at Northwestern University.
He believes that intensive care should be used with extreme caution during therapy in patients with COVID-19. Intensive care units are constantly optimized for patients, but any, even minor deviations from standard forms of treatment require practice and monitoring the results. The COVID-19 pandemic has already been recognized as unprecedented.
The disease spreads very quickly and leads to an increase in the number of critically ill patients. The treatment of patients with coronavirus in many countries has required testing of various medical resources. Doctors used various methods of therapeutic effect, determining the optimal result.
But most of them do not bring a tangible effect, causing stress for doctors who take all measures to save infected people. As hospital staff mobilized to search for new therapies for treating patients with COVID-19, specialists drew attention to a characteristic situation where new methods of therapeutic intervention not only bring no effect but also aggravate the situation of patients.
Therefore, they are forced to warn their colleagues around the world about this fact, persistently recommending using the traditional principles of intensive care instead of new methods of treatment. In theory, it is important to discuss possible ways of using other techniques, but for now, it is necessary to use a rational approach to applying scientific knowledge in a room with a patient with severe COVID-19.
To date, supportive therapy is recognized as the most effective way. Until clinical trials are conducted that offer clear guidance on a different treatment approach, modern supportive care is the best option.